Shield to distribute allergy test in UK:
This article was originally published in Clinica
UK company Shield Diagnostics is to distribute the MAST CLA in vitro allergy test, manufactured Hitachi Chemical subsidiary MAST Immunosystems. The lab test, which uses a small plastic device, the MASTpette test chamber, containing cellulose threads, can detect 36 allergens, including pollen, dust and foods, from a single blood sample. Dundee-based Shield claims to be a leading company in autoimmune disease diagnosis and says the progression into allergy testing is a logical move.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.